New Own skin care line hits Duane Reade, Whole Foods
NEW YORK — Taking a complete approach to skin health and leveraging conjugated linoleic acid — or CLA, a natural compound derived from the safflower plant — is the new skin care line called Own.
Launched in spring 2012, Own is available in Duane Reade stores and recently entered the Northern California market at Whole Foods.
“I was seeing an abundance of safe, eco-friendly skin care in the marketplace, but what I wasn’t seeing was safe, eco-friendly skin care that actually worked,” stated Alastair Dorward, founder and CEO of Own. “This revolutionary concept in skin care creates healthy, smooth skin without the harmful side effects of retinol. Consumers feel better and look better after using Own products, and that’s the most rewarding part of the business for me.”
Dorward has been a consumer goods entrepreneur since 1996, when he founded Covent Garden, a natural refrigerated soup brand. He then moved on to to become founding CEO of Method Products from its inception in March 2001 to August 2008. Own marks Dorward’s newest venture.
The skin care collection, which is exclusive to the United States, is comprised of a Rejuvenating Cleanser ($12), Lifting Eye Cream ($24), Firming Silk Concentrate ($24.99), Refining Moisture Night Cream ($24) and Dual Protecting Day Lotion with SPF 30 ($23).
FDA accepts application for Shionogi VVA treatment
FLORHAM PARK, N.J. — The Food and Drug Administration has accepted a regulatory approval application for a drug made by Shionogi for treating vulvar and vaginal atrophy due to menopause.
Shionogi, the U.S. division of Japanese drug maker Shionogi & Co., said Wednesday that the FDA had accepted for review its application for ospemifene, which the company touts as potentially the first oral alternative to vaginal estrogen treatments.
"Women spend more than a third of their lives in menopause, yet VVA is an underdiagnosed and underrated condition that significantly impacts the health and well-being of women," Shionogi president and CEO John Keller said.
Reports: Diplomat CEO says ACA boosts healthcare access but doesn’t address waste
NEW YORK — While saying the Patient Protection and Affordable Care Act — whose constitutionality the Supreme Court largely upheld in a 5-4 decision Thursday — would be beneficial by creating a larger population of insured patients, the leader of one of the country’s largest specialty pharmacies said it didn’t address the problem of waste in health care, according to published reports.
MLive.com quoted Diplomat Specialty Pharmacy CEO Phil Hagerman as saying that a reversal of the law would result in more patients being unable to obtain care, but the law in its current form left out the need to address problems like inefficiencies and fraud.
Hagerman told the Michigan-based news site that the medical industry remained "behind" in the adoption of electronic medical records and predictive modeling.